drugset
drugset / Trial / NCT06609525

Comparing Efficacy and Safety of CTO0303 in Pediatric Subjects

NCT06609525 ↗

Phase 2/3 Unknown 156 enrolled Taejoon Pharmaceutical Co., Ltd.
RandomizedParallel-groupDouble-blindDiagnostic

Summary

This is a prospective randomized study compared with active control arm.

Timeline

Start
2024-05-09
Primary completion
2024-12-31
Completion
2025-03-01

Drugs

EvaluationDrugModalityDoseRoute
Subject CTO0303-A Unknown 1 unknown Other
Subject CTO0303-B Unknown 1 unknown Other
Comparator CTO0303-C Unknown 1 unknown Other

Indications

cycloplegia